Flex Pharma (FLKS) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts FLKS Hot Sheet
Join SI Premium – FREE
Flex Pharma (NASDAQ: FLKS) reported Q3 EPS of ($0.65), $0.07 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $586 thousand versus the consensus estimate of $110 thousand.
For earnings history and earnings-related data on Flex Pharma (FLKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- John B. Sanfilippo & Son (JBSS) Misses Q4 EPS by 59c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
